MPRINT

Welcome to the Brand page for “MPRINT”, which is offered here for Biological and chemical preparations and products, for medical or veterinary purposes, for detecting, separating and analysing materials within biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for medical, biological and veterinary purposes; medical preparations made from clinical materials and specimens for treating metabolic, cardiovascular, and neurodegenerative disorders; medical products derived from biological fluids, antibodies and pharmaceutical or veterinary preparations for disease checking and testing purposes; biological products for medical diagnoses, antibodies, recombinant proteins, nucleic acids and peptides for analysing biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for veterinary diagnosis and research purposes;medical print;color is not claimed as a feature of the mark.;chemicals intended for industry, research and scientific use, marbles, marked chemicals or chemical probes for detecting, separating and analysing macromolecular complexes, organic or inorganic compounds, biological ingredients, medicines and other substances that are biologically active in biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for medical, biological and veterinary purposes;biomedical research and development services for biological, medical and veterinary products, particularly for treatment, prevention, medical diagnosis, and monitoring the clinical status and effectiveness of therapy for patients; research and development activities under contract in the fields of biotechnology, genomics, proteomics, gene expression and protein profiling, the discovery and development of medicines and the analysis of nucleic acid in the biomedical, forensics, environmental and food industries; analysis services provided by laboratories and care centres relating to testing and dosage of materials consisting of organic or inorganic compounds and biological ingredients within biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid; research and development activities under contract in the fields of medical technology, pharmaceuticals, biochemistry and genetics, scientific research services for medical purposes, maintaining, testing, extracting and providing third parties with biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid and ingredients thereof, including chemical and biological products;.

Its status is currently believed to be active. Its class is unavailable. “MPRINT” is believed to be currently owned by “Genfit”.